AU2003265057A8 - Anti-idiotypic antibodies as vegf or fgf agonists for bone therapy - Google Patents

Anti-idiotypic antibodies as vegf or fgf agonists for bone therapy

Info

Publication number
AU2003265057A8
AU2003265057A8 AU2003265057A AU2003265057A AU2003265057A8 AU 2003265057 A8 AU2003265057 A8 AU 2003265057A8 AU 2003265057 A AU2003265057 A AU 2003265057A AU 2003265057 A AU2003265057 A AU 2003265057A AU 2003265057 A8 AU2003265057 A8 AU 2003265057A8
Authority
AU
Australia
Prior art keywords
vegf
idiotypic antibodies
bone therapy
fgf agonists
fgf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003265057A
Other versions
AU2003265057A1 (en
Inventor
Karine Andre
Jean Plouet
Marie-Helene Lafage-Proust
Laurence Vico
Marc Trombe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ABTECH
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Jean Monnet Saint Etienne
Original Assignee
ABTECH
Centre National de la Recherche Scientifique CNRS
Institut National de la Sante et de la Recherche Medicale INSERM
Universite Jean Monnet Saint Etienne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ABTECH, Centre National de la Recherche Scientifique CNRS, Institut National de la Sante et de la Recherche Medicale INSERM, Universite Jean Monnet Saint Etienne filed Critical ABTECH
Publication of AU2003265057A8 publication Critical patent/AU2003265057A8/en
Publication of AU2003265057A1 publication Critical patent/AU2003265057A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
AU2003265057A 2002-09-04 2003-09-03 Anti-idiotypic antibodies as vegf or fgf agonists for bone therapy Abandoned AU2003265057A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40807602P 2002-09-04 2002-09-04
US60/408,076 2002-09-04
PCT/IB2003/004307 WO2004022095A1 (en) 2002-09-04 2003-09-03 Anti-idiotypic antibodies as vegf or fgf agonists for bone therapy

Publications (2)

Publication Number Publication Date
AU2003265057A8 true AU2003265057A8 (en) 2004-03-29
AU2003265057A1 AU2003265057A1 (en) 2004-03-29

Family

ID=31978557

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003265057A Abandoned AU2003265057A1 (en) 2002-09-04 2003-09-03 Anti-idiotypic antibodies as vegf or fgf agonists for bone therapy

Country Status (2)

Country Link
AU (1) AU2003265057A1 (en)
WO (1) WO2004022095A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2283666C9 (en) * 2004-05-14 2007-03-10 Бизяев Алексей Вячеславович Agent for accelerated repairing of structure and function of damaged tissues and organs
JOP20190083A1 (en) 2008-06-04 2017-06-16 Amgen Inc Fgf21 mutant fusion polypeptides and uses thereof
WO2010002862A2 (en) 2008-07-01 2010-01-07 Aveo Pharmaceuticals, Inc. Fibroblast growth factor receptor 3 (fgfr3) binding proteins
MX341149B (en) 2008-10-10 2016-08-09 Amgen Inc Fgf21 mutants and uses thereof.
SI3248610T1 (en) 2009-05-05 2024-03-29 Amgen Inc., Fgf21 mutants and uses thereof
AU2010246038A1 (en) 2009-05-05 2011-12-01 Amgen Inc. FGF21 mutants and uses thereof
WO2010148142A1 (en) 2009-06-17 2010-12-23 Amgen Inc. Chimeric fgf19 polypeptides and uses thereof
AU2010326024A1 (en) 2009-12-02 2012-07-05 Amgen Inc. Binding proteins that bind to human FGFR1c, human beta-Klotho and both human FGFR1c and human beta-Klotho
UA109888C2 (en) 2009-12-07 2015-10-26 ANTIBODY OR ANTIBODILITY ANTIBODY OR ITS BINDING TO THE β-CLOTE, FGF RECEPTORS AND THEIR COMPLEXES
CN116323666A (en) 2020-08-21 2023-06-23 建新公司 FGFR3 antibodies and methods of use
CN112094351B (en) * 2020-09-11 2021-04-20 北京东方百泰生物科技股份有限公司 Detection antibody of anti-VEGFR-2 monoclonal antibody, application and detection method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0836380T3 (en) * 1995-06-12 2002-04-22 Yeda Res & Dev FGF9 as a specific ligand for FGFR3
FR2742662B1 (en) * 1995-12-21 1998-01-23 Centre Nat Rech Scient ANTI-IDIOTYPIC ANTIBODIES OF VASCULAR ENDOTHELIAL GROWTH FACTOR AND THEIR USE AS MEDICAMENTS
WO2000064261A1 (en) * 1999-04-26 2000-11-02 Ludwig Institute For Cancer Research Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof
FR2796073B1 (en) * 1999-07-07 2003-08-29 Centre Nat Rech Scient ANTI-IDIOTYPIC ANTIBODIES FOR FIBROBLAST GROWTH FACTORS AND THEIR USE AS MEDICAMENTS
IL139380A0 (en) * 2000-10-31 2001-11-25 Prochon Biotech Ltd Active variants of fibroblast growth factor

Also Published As

Publication number Publication date
WO2004022095A1 (en) 2004-03-18
AU2003265057A1 (en) 2004-03-29

Similar Documents

Publication Publication Date Title
IL164867A0 (en) Use of vegf for treating bone defects
EE200200355A (en) EP4 receptor selective agonists for the treatment of osteoporosis
ZA200604778B (en) Azabicyclic heterocycles as cannabinoid receptor modulators
IS7670A (en) Combination therapy for proliferative disease
IL169633A0 (en) Combination therapy for treating protein deficiencies
HUS2200036I1 (en) Use of dihydroimidazolones for the treatment of dogs
EE200300246A (en) EP4 receptor selective agonists for the treatment of osteoporosis
IL206984A0 (en) Analoges of benzoquinone-containing ansamycins for the treatment of cancer
GB0325523D0 (en) Apparatus for predicting bone fracture risk
HU0200264D0 (en) Estrogen agonists/antagonists for the treatment of certain cancers
ZA200508198B (en) Beta-carbolines useful for treating inflammatory disease
AU2003290059A8 (en) Use of cd137 antagonists for the treatment of tumors
AU2003265057A8 (en) Anti-idiotypic antibodies as vegf or fgf agonists for bone therapy
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
GB0419954D0 (en) System for directing therapy
FI20030247A (en) Refractory tank and lining for this
IL165242A0 (en) Treatment for diabetes
GB2392618B (en) Compositions for therapeutic use
GB0208986D0 (en) Apparatus for the game of latrey
AP2006003613A0 (en) Oral formulations for 5-HT-receptor agonists, usesand methods of treatment employing the same
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
GB0413822D0 (en) Bone fixator
GB0315058D0 (en) Patient transportation apparatus
EP1569689A4 (en) Combination il2/anti-her2-antibody therapy for cancers characterized by overexpression of the her2 receptor protein
GB0209135D0 (en) Fiber treatment composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase